Myanmar FDA registration 42b52d20b7bd58f1ab415da2005a32a1

MAGLUMI® β2-Microglobulin (CLIA)

Name: MAGLUMI® β2-Microglobulin (CLIA) — Myanmar FDA registration 42b52d20b7bd58f1ab415da2005a32a1
Creator: Shenzhen New Industries Biomedical Engineering Co., Ltd.
Keywords: MAGLUMI® β2-Microglobulin (CLIA), MAGLUMI® β2-Microglobulin (CLIA), Maglumi, 42b52d20b7bd58f1ab415da2005a32a1, Myanmar FDA registration

MyanmarMaglumiShenzhen New Industries Biomedical Engineering Co., Ltd.Registered November 15, 2022

VerifiedFDA Myanmar · official registry

Device classification

Brand Name: Maglumi

Registration information

Analysis ID: 42b52d20b7bd58f1ab415da2005a32a1
Registration Date: November 15, 2022

Manufacturer

Name: Shenzhen New Industries Biomedical Engineering Co., Ltd.

Authorized Representative

Name: BIOMED MYANMAR COMPANY LIMITED

About this record

Access comprehensive regulatory information for MAGLUMI® β2-Microglobulin (CLIA) in the Myanmar medical device market through Pure Global AI's free database. This medical device is registered under FDA ID 42b52d20b7bd58f1ab415da2005a32a1 and manufactured by Shenzhen New Industries Biomedical Engineering Co., Ltd.. The device was registered on November 15, 2022.

This page provides complete registration details including manufacturer information, authorized representative details, and regulatory compliance data from the official Myanmar FDA medical device database. Pure Global AI offers free access to Myanmar's complete medical device registry.